Actions

Extra: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 1: Line 1:
HLA-DR
CD34


:HLA-DR is considered a pan-B lineage  marker in leukaemia and in cases where lineage is ambiguous the expression of HLA-DR may contribute to (but not prove) the assignment of B cell lineage. The molecule is also expressed by myeloid blasts, but rarely by promyelocytes so has value in identification of acute promyelocytic leukaemia (APL).
*Often regarded as a marker of primitive phenotype, CD34 is expressed by many cases of ALL (around 50%) and slightly fewer cases of AML around (40%)
*CD34 is also expressed by regenerating cells in marrow, and particularly by regenerating B lymphocytes (haematogones)  


details  
what is its normal function and expression  
HLA-DR presents antigen to T-helper cells and is typically expressed by cells involved in antigen processing and recognition - including macrophages, B-cells and dendritic cells. HLA-DR is also expressed by early myeloid progenitor cells but expression is lost as they mature to promyelocytes.  
CD34 is a membrane protein that is likely to play a role in the retention of cells within the stem cell niche where it may also contribute to their subsequent maturation. CD34 is acquired at the stage of pluripotent stem cells and is retained by committed stem cells before being lost as the cells mature. CD34 is also expressed by mast cells and by some non-haematopoietic cells particularly endothelial cells.  


Use
what is its diagnostic role 
*Acute myeloid leukaemias generally express HLA-DR, but expression is expected to be absent from mature myeloid leukaemias such a APL and erythroid leukaemia
*CD34 is commonly used to identify the primitive nature of early lymphoid or myeloid cells i.e. blast cells of ALL and AML
*B-lineage leukaemias and lymphomas each will usually express HLA-DR, although expression is generally lost as they mature to plasma cells
*Rare very primitive cases of acute leukaemia may be identified solely through their expression of CD34 and CD45
*T-lineage ALL is generally HLA-DR negative, although rarely mature T-cell neoplasms may express HLA-DR
*CD45 is also expressed by regenerating cells in marrow and also by regenerating haematogones so caution is necessary in interpretation in regenerating marrows 
 
other relevant information 
Histopathologists often use CD34 to demonstrate the number of primitive cells in bone marrow trephine biopsies e.g. in the assessment of primitive cell number in myelodysplaia; however a range of other cell types in bone marrow also express CD34 in marrow, and these include vascular endothelial cells and mast cells.
 
----  summary tables 
1. expression by acute leukaemias and by haematogones
freq  pro-b all
freq  early pre-b all 
freq  pre-b all 
poss  b all 
freq  pro-t all 
freq  mature-t all
freq  aml 
hi  haemato-gones 
* in aml expression is rare in apl and is less frequent in npm1-mutated patients, Burkitt 
 
2. expression by b-lymphoproliferative disorders
rare cll
rare  pll
rare  mcl
rare  fl link
rare  hcl
rare  hclv
rare  mzl
rare  lpl
rare  pcs

Revision as of 12:40, 17 May 2023

CD34

  • Often regarded as a marker of primitive phenotype, CD34 is expressed by many cases of ALL (around 50%) and slightly fewer cases of AML around (40%)
  • CD34 is also expressed by regenerating cells in marrow, and particularly by regenerating B lymphocytes (haematogones)

what is its normal function and expression CD34 is a membrane protein that is likely to play a role in the retention of cells within the stem cell niche where it may also contribute to their subsequent maturation. CD34 is acquired at the stage of pluripotent stem cells and is retained by committed stem cells before being lost as the cells mature. CD34 is also expressed by mast cells and by some non-haematopoietic cells particularly endothelial cells.

what is its diagnostic role

  • CD34 is commonly used to identify the primitive nature of early lymphoid or myeloid cells i.e. blast cells of ALL and AML
  • Rare very primitive cases of acute leukaemia may be identified solely through their expression of CD34 and CD45
  • CD45 is also expressed by regenerating cells in marrow and also by regenerating haematogones so caution is necessary in interpretation in regenerating marrows

other relevant information Histopathologists often use CD34 to demonstrate the number of primitive cells in bone marrow trephine biopsies e.g. in the assessment of primitive cell number in myelodysplaia; however a range of other cell types in bone marrow also express CD34 in marrow, and these include vascular endothelial cells and mast cells.


summary tables

1. expression by acute leukaemias and by haematogones freq pro-b all freq early pre-b all freq pre-b all poss b all freq pro-t all freq mature-t all freq aml hi haemato-gones

  • in aml expression is rare in apl and is less frequent in npm1-mutated patients, Burkitt

2. expression by b-lymphoproliferative disorders rare cll rare pll rare mcl rare fl link rare hcl rare hclv rare mzl rare lpl rare pcs